Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
Clinton Otwori, Perioperative Nurse at LifeCare Hospitals, shared a post on LinkedIn:
“Different blood products.
Different purposes.
Different risks.
Not every blood bag hanging in the ward or ICU serves the same purpose.
And understanding the difference can save lives.
Whole Blood still used in many emergency settings for:
- Massive blood loss
- Trauma
- Hemorrhagic shock
Provides:
- Red cells
- Plasma
- Clotting factors
- Platelets
Packed Red Blood Cells (PRBCs)
Used mainly to improve oxygen-carrying capacity in:
- Severe anemia
- Surgical blood loss
- Hemorrhage
Fresh Frozen Plasma (FFP)
Used for:
- Clotting factor replacement
- Coagulopathy
- Liver disease-related bleeding
- Massive transfusion protocols
Platelets
Used when platelet counts are dangerously low or bleeding risk is high.
Common indications include:
- Thrombocytopenia
- Active bleeding
- Platelet dysfunction
Cryoprecipitate
Rich in fibrinogen and clotting factors.
Used in:
- Low fibrinogen states
- Massive bleeding
- Selected DIC cases
The dangerous part?
Two blood products may look similar
But giving the wrong one can:
- Delay treatment
- Worsen complications
- Increase patient risk
And transfusion itself is never risk-free.
Healthcare workers should always watch for:
- Fever/chills
- Shortness of breath
- Rash/itching
- Back or flank pain
- Hypotension or tachycardia
Before any transfusion:
- Verify the patient carefully
- Confirm compatibility
- Monitor closely
- Reassess continuously
Because in critical care…
The right blood product at the right time can save a life.
Which blood product do you think healthcare workers most commonly misunderstand in practice?”
Stay updated with Hemostasis Today.
-
May 26, 2026, 03:02Spelile Mutupira: Process of Blood Clotting After Injury
-
May 26, 2026, 02:58Toriqul Islam: EDTA-Induced Pseudothrombocytopenia
-
May 26, 2026, 02:34James O’Donnell Secures 2 Million Euros for a New Programme on The Irish ABO and Coagulation Study – RCSI
-
May 26, 2026, 02:26Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal
-
May 26, 2026, 01:42Mili Doshi: The Role of Oral Health Teams in Supporting Stroke Rehabilitation and Recovery
-
May 26, 2026, 01:25Mohamed Mamdouh: Advancing Stroke Care Access in Cairo Through the Launch of a New Stroke-Ready Center
-
May 26, 2026, 01:15Tom Lazenby: Accelerating Rare Disease Drug Development Through MHRA’s Investigational Marketing Authorisation
-
May 25, 2026, 22:15Cedric Hermans: What Is Still To Be Discovered and To Be Redefined in The Treatment of Haemophilia A?
-
May 25, 2026, 16:27Gashaw Arega: Advancing Bleeding Disorders Care in Africa